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Abstract
Gluconeogenesis, glycolysis and glycogenolysis were studied in rat perfused liver following the infusion of various
 .concentrations of diclofenac and aspirin, two non-steroidal anti-inflammatory drugs NSAIDs . Glucose synthesis was
measured in livers isolated from 48-h fasted rats perfused with Krebs-Henseleit bicarbonate buffer containing L-lactate 2
.  .  .  .mM and pyruvate 0.1 mM as precursors. Both diclofenac 0.01–0.1 mM and aspirin 1–10 mM had an inhibitory effect
 .on gluconeogenesis GNG . The inhibition was dose-dependent and reversible. For the estimation of glycogenolysis and
glycolysis, the rates of glucose release and of lactate and pyruvate production were measured in livers of well-fed rats
 .  .perfused with substrate-free buffer. Infusion of diclofenac 0.1 mM or aspirin 5 mM strongly stimulated glycogenolysis
 .and glycolysis GGLrGL . In general, an increased oxygen consumption by the liver tissue was also noted in both types of
experiments, as deduced from the continuous monitoring of oxygen concentration changes in the effluent. Such a pattern of
response can be attributed to the uncoupling effects of the two drugs on oxidative phosphorylation. Measurements of
respiration rates and membrane potential in isolated liver mitochondria submitted to various concentrations of diclofenac
and aspirin confirms this assumption. Thus, 0.01 to 0.2 mM diclofenac stimulates state-4 respiration and slightly inhibits
state 3, decreasing the respiratory control ratio, while the membrane potential is decreased or collapsed depending on the
.  .drug concentration . Similar effects are recorded for aspirin at higher concentrations 0.2–5 mM , even though state 3 is not
affected in this case. Arguments are presented that the concentrations of the drugs used largely correspond to the
pharmacological doses employed in antipyretic and anti-inflammatory treatments. Therefore, a greater consideration should
be given to the uncoupling effect, at least from the toxicological viewpoint.
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1. Introduction
w xAccording to a hypothesis proposed by Vane 1 , it
has been accepted for almost 20 years that non-
 .steroidal anti-inflammatory drugs NSAIDs , such as
diclofenac and aspirin, act by inhibiting the synthesis
of specific prostaglandins. However, certain experi-
mental discrepancies between the extent of the inhibi-
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tion of prostaglandin biosynthesis and the anti-in-
 w x.flammatory efficiency see Refs. 2–4 as well as
other observations determined Weissmann’s group
w x2,3 to advance a new hypothesis, based on the
capacity of NSAIDs to disrupt a series of
membrane-dependent processes, including signal
transduction at the level of plasmalemma.
In a preliminary study dedicated to the effects of
diclofenac on the metabolism of the perfused liver of
rat, we noticed a rather strong effect of this drug on
 .both gluconeogenesis inhibition and glycogenolysis
 .stimulation , at concentrations calculated by us to be
similar to those used in anti-inflammatory treatments.
Such a pattern of response, associated with an in-
creased tissue oxygen consumption, suggested as a
logical explanation an uncoupling effect on oxidative
phosphorylation, which was also confirmed by the
w xliterature data for other NSAIDs 5–11 .
However, the uncoupling effect, which is in gen-
eral accompanied by heat production and Ca2q re-
 w x.lease from mitochondria see, for example, Ref. 12
is apparently at variance with the anti-inflammatory
action, regardless of the hypothesis considered for the
explanation of this action. These intriguing observa-
tions prompted us to look more deeply into the
problem, extending the study to aspirin the most
.common NSAID and to isolated mitochondria, for a
more direct evaluation of the uncoupling effect.
Although the effect of aspirin on oxygen consump-
w xtion of liver slices 11 and isolated mitochondria
w x6,7,10 is a rather old observation, diclofenac has not
been studied from this point of view and neither
aspirin nor diclofenac have been employed in the
perfused liver. In fact, there is only one conspicuous
study of this type, dedicated to the effect of mefe-
 .namic acid also an NSAID on glucose metabolism
w xin the perfused liver of rat 9 .
w xIn our preliminary studies 13,14 we have also
combined the above-mentioned approach with record-
ings of mitochondrial swelling and ultrastructural
aspects of the perfused liver and isolated mitochon-
dria of both rat and guinea pig. The present paper
presents our final and most important results regard-
ing the effects of diclofenac and aspirin on glucose
metabolism in the perfused liver of rat and on oxida-
tive phosphorylation of isolated hepatic mitochondria.
2. Materials and methods
2.1. Li˝er perfusion and related methodology
Male albino rats of an inbred Wistar line 200–250
.g were anesthesized by intraperitoneal injection of
 .sodium pentobarbital 50 mgrkg body weight and
after the removal of viscera the liver was perfused in
w xsitu, as previously described 15,16 . The liver was
 .cannulated via the hepatic portal vein for influx and
the supradiaphragmatic portion of the inferior vena
 . cava for efflux . A non-recirculating i.e., through-
.flow hemoglobin-free perfusion was used. The per-
fusion medium, Krebs-Henseleit bicarbonate buffer
 .pH 7.3–7.4 , was pumped into the liver with the aid
of a peristaltic pump, at a rate of 32.5–33.0 mlrmin.
The flow rate was constant for the same liver during
the entire period of perfusion. The perfusion medium
 .was continuously gassed with O :CO 19:1 and2 2
oxygenated by a rotatory disc oxygenator. The glu-
 .cose precursors i.e., lactate and pyruvate and the
drugs were dissolved in the perfusion medium and
pumped into an in-line infusion chamber with the aid
of an infusion pump, so as to enter the liver at a
 .constant rate 0.2–0.4 mlrmin and to give the de-
sired final concentration in the perfusion medium.
When necessary, the compounds to be presented to
the liver were brought to pH 7.4 with NaOH or HCl.
Drug concentrations administered in the perfusion
were in the usual range employed in such studies.
Thus, diclofenac was varied from 0.01 to 0.1 mM,
whereas aspirin from 1 to 10 mM. These figures
parallel the normal clinical doses used in inflamma-
w xtion treatments, i.e., 150 mgrday for diclofenac 17
w xor 5–8 grday for aspirin 4 .
For a complete depletion of the hepatic glycogen
reserve, 48-h-fasted rats were used in GNG studies.
In this case, 2 mM lactate and 0.1 mM pyruvate
 .final concentrations in the perfusion medium were
 .employed as glucose precursors substrates . The ef-
fects on GGL and GL were studied on livers obtained
from well-fed rats perfused with medium without
substrate. The intensity of glycogenolysis was esti-
mated by measuring glucose liberation from endoge-
nous glycogen, whereas the intensity of glycolysis
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was estimated through the lactate and pyruvate origi-
nating from glucose catabolism.
Changes of oxygen concentration in the effluent
were monitored continuously using an in-line oxygen
electrode attached to a potentiometric recorder. A
value of 2.07 matoms of oxygenrml perfusion
medium was used as a basis for calculating oxygen
concentration. This was expressed as an oxygen quo-
 .tient QO , in matoms oxygenr100 g body weight2
and hour. This way of expression is needed because
the oxygen concentration in the effluent depends not
only on the rate of oxygen consumption by the tissue
but also on the perfusion rate. At a constant oxygen
consumption by liver, the concentration of oxygen in
the effluent will be higher at higher perfusion rates,
when more oxygen passes through the system in the
time unit.
Effluent samples were collected at 3-min intervals
and assayed spectrophotometrically for glucose, lac-
tate and pyruvate, immediately after the perfusion
end, using the appropriate Biochemica Combination
kits, depending on the experiment.
2.2. Isolation of mitochondria and the measurement
of respiration-dependent parameters
Mitochondria were isolated from the livers of
freshly decapitated animals, essentially according to
w xRef. 18 . The isolation medium consisted of 250 mM
 .sucrose, 10 mM Tris-HCl pH 7.4 and 0.1 mM
EDTA, while the final washing and suspending me-
dia lacked the chelating agent.
Respiration rates were measured polarographically
at 258C, in a 0.5-ml cell, with a Clark oxygen
 .electrode Yellow Springs , in a medium consisting
of 175 mM sucrose, 50 mM KCl, 10 mM phosphate
 .buffer, 20 mM Tris pH 7.4 , 0.5 mM EDTA and 2
 . mM MgSO . Glutamate 10 mM plus malate 54
.  .  .mM or succinate 10 mM potassium salts were
used as respiratory substrates. Mitochondria 1
.mgrml with succinate or 2 mgrml with glutamate
were injected through the stopper capillary and the
oxygraphic traces recorded in this way represented
the basal respiration basal state or state 2; see Ref.
w x .12 for nomenclature . After 1–2 min, 0.1–0.2 mM
ADP was injected, resulting in the so-called state 3
respiration, characterised by a higher rate of oxygen
consumption. When ADP was exhausted i.e., phos-
.phorylated to ATP , the respiration rate decreased
 .again, resulting in state 4 similar to the basal state .
The ratio between the state 3 and the basal state is
 .known as the acceptor control ratio ACR , whereas
the ratio between state 3 and state 4 is known as the
 .respiratory control ratio RCR . They have similar
values and significances, both representing important
indices of mitochondrial integrity and phosphoryla-
w xtion ability 12 .
Diclofenac or aspirin were usually injected at state
4, but in some cases they were added at state 3 or
even at the basal state, from a buffered stock solu-
Fig. 1. Effect of successive additions of low concentrations of
diclofenac on glucose synthesis and oxygen evolution in the
perfused rat liver. The conditions are as described in Section 2.
QO , depicted in the ordinate, represents the oxygen level2
recorded by the electrode immersed into the hepatic effluent,
correlated to animal weight and flow rate. This coefficient is a
negative reflection of specific oxygen consumption by the liver
tissue.
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tion, so as to obtain the desired final concentration in
the oxygraph cell. In fact, all the concentrations
mentioned above or which will appear later in this
presentation refer to final concentrations in the reac-
tion mixture.
Membrane potential generated by succinate respi-
ration and the kinetic behaviour of this potential
following the addition of ADP and the tested drugs
were monitored by spectrophotometric recording of
 .the absorbance changes at 660 nm of the membrane
 .potential-sensitive probe diS-C - 5 , in a Specord-M-2
 .40 spectrophotometer Carl Zeiss , based on previ-
w xously described principles 19,20 and methodology
w x21 . It should be mentioned, however, that it was not
our intention to measure absolute values of mem-
brane potential but to use the absorbance changes in a
Fig. 2. Strong effect of a high concentration of diclofenac 0.1
.mM on glucose synthesis and oxygen evolution in the perfused
rat liver.
Fig. 3. Effect of increasing concentrations of aspirin on gluconeo-
genesis in the perfused rat liver.
qualitative manner, mainly for kinetic observations.
The basic suspending medium consisted of: 100 mM
 .sucrose, 80 mM KCl, 5 mM Tris-Hepes pH 7.3 , 5
mM KP , 2 mM MgCl and 0.5 mM EDTA. Specifici 2
details of this type of experiments can be found in the
corresponding figure legends.
2.3. Chemicals
Biochemica Test-Combination kits for glucose
 .GOD-Perid , lactate and pyruvate and all enzymes
and coenzymes used for assays were from
Boehringer-Mannheim GmbH. Tris and pyruvate were
 .from Merck Darmstadt and lactate from Riedel-de-
 .Haen Hanover . ADP, rotenone and oligomycin were¨
 .purchased from Sigma and diS-C - 5 from2
Eastman-Kodak. Diclofenac and aspirin were from
 .the Romanian Drug Enterprises Bucharest . All other
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chemicals were of the highest purity commercially
available.
3. Results
3.1. Effects of diclofenac and aspirin on hepatic
gluconeogenesis
As can be seen in Fig. 1, the first 15 min of
perfusion with Krebs-Henseleit bicarbonate medium
alone are characterised by a very low content of
glucose in the effluent. The addition of lactate and
pyruvate in the perfusion medium induces a very
rapid increase of glucose synthesis, which remains
 .Fig. 4. Effect of a high concentration of diclofenac 0.1 mM on
glycogenolysis, glycolysis and oxygen evolution in the perfused
rat liver.
 .Fig. 5. Effect of a high concentration of aspirin 5 mM on
glycogenolysis, glycolysis and oxygen evolution in the perfused
rat liver.
constant over the entire period of substrate adminis-
tration, if no other addition is made. However, di-
 .clofenac administration 0.02–0.1 mM determines a
 .decrease of GNG Figs. 1 and 2 . The inhibition of
glucose synthesis is proportional to diclofenac con-
centration and lasts as long as the drug is present in
the perfusion medium. The interruption of diclofenac
administration restores the normal glucose synthesis.
It is worth noting that oxygen quotient in the effluent
also decreases in the presence of diclofenac see
.especially Fig. 1 , meaning an increased oxygen con-
sumption by the liver tissue. However, at 0.1 mM
 .drug Fig. 2 , where GNG is 80% inhibited, after an
initial slight increase, the trend of oxygen consump-
tion reverses.
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As in the case of diclofenac, the presence of
 .aspirin 1–10 mM in the perfusion medium induces
the inhibition of GNG and the decrease of oxygen
 .quotient Fig. 3 . Similarly, the inhibition is propor-
tional to the drug concentration and it is reversible.
3.2. Effects of diclofenac and aspirin on hepatic
glycogenolysis and glycolysis
As can be seen from Fig. 4, the administration of
 .diclofenac 0.1 mM in the perfusion medium deter-
mines an increase of both GGL and GL. A slight
decrease of oxygen quotient can also be observed.
The effects are reversible for all the parameters tested.
 .Aspirin 5 mM also produces an increase of both
 .GGL and GL Fig. 5 . The visible decrease of oxygen
quotient in the effluent indicates a strong increase of
oxygen consumption by the liver tissue during aspirin
administration. The effects are, again, reversible.
3.3. The effects of diclofenac and aspirin on respira-
tion
The effects of various concentrations of diclofenac
on the respiratory parameters of rat liver mitochon-
dria are presented in Fig. 6.
Fig. 6 shows several oxygraphic traces recorded in
the presence of glutamate plus malate. In trace a,
after about 1 min of basal respiration following the
.addition of mitochondria , the respiration is stimu-
lated by injection of ADP, attaining 89.9 ng atoms
 .Orminrmg protein state 3 . After ADP exhaustion,
the respiration rate decreases to 18.6 ng atoms
 .Orminrmg protein state 4 . The ratio between the
 .two states RCR is 4.83. Diclofenac added now on
state 4 stimulates the respiration proportionally to its
concentration. The highest concentration used 0.2
. mM stimulates the respiration by 166% 49.6r18.6
. s2.66 . When diclofenac is added on state 3 trace
.  .b , a small inhibition occurs about 25% at 0.1 mM .
If oligomycin which inhibits the utilisation of
.ADPrATP is added on state 3, the resulting low
 .respiration rate can be increased 77% by the con-
 .secutive addition of 0.1 mM diclofenac trace c . This
phenomenon is in general similar to but less exten-
.sive than that produced by 0.1 mM dinitrophenol
 . DNP , a classical uncoupling agent see trace d as an
illustration of the removal of oligomycin inhibition
.by DNP . Similar effects could be observed on succi-
 w x.nate-dependent respiration see Ref. 14 .
 .High concentrations of aspirin 0.2–5 mM also
have uncoupling effects. This is demonstrated by the
 .Fig. 6. Effects of the addition of diclofenac on different respiration states of rat liver mitochondria. 1 mg of mitochondrial protein Mit is
suspended in the 0.5-ml oxygraph cell under conditions described in Section 2 for glutamate respiration. This is followed by the addition
of 0.2 mM ADP and different drugs, as indicated by arrows: DCFsdiclofenac, Oligosoligomycin, DNPs2,4-dinitrophenol see text
.for other details .
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recordings shown in Fig. 7. Trace a of Fig. 7 repre-
sents the control. Trace b in Fig. 7 shows that aspirin
added on state 4 stimulates the respiration proportion-
ally to its concentration. The respiration is also stimu-
 .lated if aspirin 2 mM is added directly on the basal
 .state trace c . However, the same concentration of
 .aspirin has no effect on state 3 trace d . Added after
oligomycin, 5 mM aspirin partly removes the inhibi-
 .tion produced by that drug trace e . As in the case of
diclofenac, succinate-dependent respiration is also af-
 w x.fected see Ref. 14 .
3.4. Effects on membrane potential
Since uncouplers affect membrane permeability,
 w x.especially for protons see, for example, Ref. 12 ,
we expect that diclofenac and aspirin decrease mem-
brane potential difference generated by mitochondrial
respiration. As can be seen in Fig. 8, this phe-
nomenon does indeed occur. However, the actual
concentration of diclofenac necessary for a total col-
lapse of membrane potential differs from one individ-
Fig. 8. Effect of diclofenac on membrane potential developed by
succinate respiration in rat liver mitochondria. The suspendng
 .medium 1.5 ml in each cuvette consists of 100 mM sucrose, 80
 .mM KCl, 5 mM Tris-Hepes pH 7.3 , 5 mM KP , 2 mM MgCl ,i 2
0.5 mM EDTA and 6.6 mM rotenone. 1 mg of mitochondrial
 .protein is added in each cuvette and 2.5 mM diS-C - 5 to the2
sample, the baseline being controlled by a zero adjusting pro-
gramme. The additions indicated in the figure are made concomi-
tently into both cuvettes.
Fig. 7. Effects of the addition of aspirin on different respiration states of rat liver mitochondria. Conditions are identical to those described
in Fig. 6.
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Fig. 9. Effect of aspirin on membrane potential developed in rat
liver mitochondria. Conditions are identical to those in Fig. 8.
ual preparation to another. The trace presented in Fig.
8 results from a sensitive liver preparation, where less
than 0.1 mM diclofenac collapses the membrane
 .potential. For another preparation not shown here ,
we had to use approx. 0.25 mM drug in order to
obtain the full collapse of the membrane potential.
 .A high concentration of aspirin at least 5 mM
also produces the collapse of the membrane potential
generated by succinate respiration in rat liver mito-
 .chondria Fig. 9 . As can be seen, however, 3.3 mM
aspirin is not enough to collapse the membrane po-
tential irreversibly, a slight tendency of recovery
being observed. The results are in total agreement
with those obtained by the oxygraphic method.
4. Discussion
From the results presented above, the effects of
diclofenac and aspirin on carbohydrate metabolism
can be summarised in terms of a stimulation of
glycogenolysisrglycolysis and an inhibition of gluco-
neogenesis. As is well known, glycolysis is the only
source of energy in the eukaryotic cell under anaero-
bic conditions or when oxidative phosphorylation is
uncoupled. By releasing the pressure exerted on the
electron flow, uncoupling stimulates the respiration in
a futile cycle. For thermodynamic reasons, under
these conditions, glycogenolysis and glycolysis are
also expected to be stimulated and produce the neces-
sary ATP for the cell. Thus, the stimulating effects of
the two drugs on GGLrGL could be the result of an
uncoupling process. In fact, our data obtained on
isolated mitochondria provide more direct evidence
for the uncoupling phenomenon. This evidence can
 .be summarised as follows: 1 stimulation of state 2
 .the basal state and of state 4 of the respiration, with
a consequent decrease of ACR and RCR, respec-
 .tively; 2 partial removal of the respiratory inhibition
 .produced by oligomycin; 3 decrease and even col-
lapse of the membrane potential.
All these effects, also supported by swelling stud-
ies and electronmicroscopic observations presented
w xelsewhere 14 , are characteristic of uncouplers and
can be easily explained in terms of the chemiosmotic
w xtheory of energy conversion in mitochondria 12,22 .
In fact, by their chemical structure, diclofenac, as-
pirin and other NSAIDs are usually monocarboxylic
acids with one or two aromatic rings. Such structures
are more or less hydrophobic, with different degrees
 w x.of membrane solubility see Ref. 9 , having a struc-
ture resembling that of typical uncoupling agents, i.e.,
compounds capable of carrying protons across lipid
w xmembranes 23 . The resemblance of diclofenac and
 .aspirin with dinitrophenol a classical uncoupler can
be seen in Fig. 10.
By virtue of this resemblance, the uncoupling ef-
fects of NSAIDs are not only possible but expected.
 .We have observed that even other more or less
hydrophobic agents with a smaller degree of similar-
ity, such as different local anesthetics and analgesics
w xare capable of producing uncoupling effects 21 . The
biochemical results presented here are, in fact, in
w xagreement with those of Kemmelmeier and Bracht 9
Fig. 10. Similarity between the two NSAIDs used and a classical
 .uncoupler DNP .
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obtained with mefenamic acid in rat perfused liver.
w xAlso, Brass and Garrity 8 , working on isolated
hepatocytes, find that certain NSAIDs such as
.meclofenamate, ibuprofen and indomethacin inten-
w xsify glycolysis. Itinose et al. 24 observe the stimula-
tion of glycogenolysis and glycolysis and the inhibi-
tion of gluconeogenesis by the analgesic drug ac-
etaminophen.
Considering the relatively hydrophobic properties
of NSAIDs and the observation that they start uncou-
pling at rather low nominal concentration, it is to be
expected that these drugs accumulate at a higher ratio
in the membranes than in the rest of the cell. Thus,
uncoupling is more likely produced not only by
specific proton transport as in the case of the true
.uncouplers , but also through membrane disordering
 .at least at higher concentrations . The observation
that at high concentrations diclofenac starts inhibiting
state 3 respiration indicates that the integral mem-
brane proteins, such as the respiratory complexes, can
also bind these drugs. The fact that diclofenac or
aspirin added to rat liver mitochondria after oly-
gomycin stimulate respiration much less than DNP
may also reflect a direct effect of these drugs on the
mitochondrial ATPase or at least on an ATP utilising
process. However, different uncoupling efficiencies
of the two drugs should also be considered in this
respect.
In the case of the local anesthetics, a good correla-
tion could be established between the degree of hy-
drophobicity and the uncoupling potency of a series
w xof tertiary amines 21 .
Although it is often stated or implied e.g., Refs.
w x.8,9 that uncoupling occurs at concentrations higher
than those considered pharmacologically relevant, our
 .results as well as the analysis of the literature data
suggest a different situation. Thus, there is a certain
parallelism between the concentrations needed for
uncoupling and for the analgesic or the anti-in-
flammatory effects of NSAIDs. According to the data
w xpresented in Ref. 4 , the peak plasma concentration
of aspirin in patients treated for inflammation is 2
mM, whereas the tissue concentration is even higher
 .12 mM , which means that aspirin exerts its anti-in-
flammatory effects at concentrations at which its
uncoupling action is very clear. Of course, it may be
argued that the real concentration in the liver tissue
could increase appreciably due to the binding which
would occur during the perfusion when the drug is
.infused at a constant rate . Although a certain degree
of binding is likely to occur, as shown for diclofenac
w xby clearance studies 25 , there are two arguments
against a strong and extensive binding. Since the
effects are dose-dependent, a large increase in the
bound drug should lead to a large time-dependent
increase in the effects. At least for aspirin, our data
show that this is not the case, the main effect being
produced immediately after the addition of the drug,
although, in the case of diclofenac, a slight time-de-
pendent additive effect can be observed. The fast
reversibility of the effects also argue against a strong
and extensive binding, even in the case of diclofenac.
Thus, most likely, uncoupling occurs at concentra-
tions close to the pharmacological doses. Therefore,
we think that more attention should be given to this
phenomenon, at least from the toxicological view-
point.
Based on the available information, one could
probably argue that the uncoupling effect has some
importance in the analgesic action of NSAIDs and
similar drugs. The anti-inflammatory action, how-
ever, can hardly be reconciled with the uncoupling
effect, which has two important consequences: Ca2q
w xrelease from mitochondria and heat liberation 12 .
Calcium is implicated as a second messenger in
the control of many cellular events see, for example,
w x.Ref. 26 , including the aggregation of the inflamma-
tion cells and the release of the inflammatory factors
w x 2q2,3 . Therefore, an increase of Ca in the cytosol
would not stop the inflammation but stimulate this
process. For glucose metabolism, however, Ca2q re-
lease may represent one of the mechanism by which
uncoupling can influence it. More specifically, glyco-
gen phosphorylase the key enzyme in glycogen
.breakdown , which is stimulated by increased cal-
w xcium concentration 27 will intensify GGL and GL.
Also, under the conditions of high levels of cytosolic
calcium, the reaccumulation of this ion by mitochon-
dria or its extrusion from the cell, which are energy-
dependent processes of the highest priority, can easily
compete with GNG and thus inhibit it.
As regards the heat dissipation, its consequences
for the specific action of NSAIDs are very debatable.
Logically, heat should increase the inflammation pro-
cess. Nevertheless, experience shows that cold and
.not heat is among the triggering factors of acute
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inflammation. Thus, despite an apparent incompati-
bility, uncoupling may have a certain significance for
the action of NSAIDs.
It is clear, however, that such a complicated pro-
cess as the anti-inflammatory action involves much
more components of the cell than the lipid phase of
the membrane which mediates the uncoupling phe-
.nomenon . So far, the limited understanding of the
metabolic regulation especially, that of energy con-
.trol of such intricate processes does not provide a
clear cause–effect relationship. Even the effect of
NSAIDs on carbohydrate metabolism, which must be
a secondary one, may be much more complicated
than we described. For example, it has been shown
relatively recently that, in the perfused liver, certain
prostaglandins of the type involved in the inflamma-
.tion process are able to stimulate both glycogeno-
w x w xlysis 28 and gluconeogenesis 29,30 . However,
since the concentration of prostaglandins in our study
was not measured, it is difficult to assess the rele-
vance of such observations for the uncoupling phe-
nomenon, proposed by others and further documented
by us as the main mechanism by which NSAIDs
affect glucose metabolism.
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